CCDC89
Coiled-coil domain-containing protein 89
Also known as: CCD89_HUMAN, FLJ38159
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N998
- Gene
- CCDC89
- Ensembl
- ENSG00000179071
- Chromosome
- 11
- Canonical length
- 374 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
374 residues, UniProt reviewed canonical sequence.
>Q8N998|CCDC89
1 MRAPMLQKQQ APRMDTPPPE ERLEKQNEKL NNQEEETEFK ELDGLREALA NLRGLSEEER
61 SEKAMLRSRI EEQSQLICIL KRRSDEALER CQILELLNAE LEEKMMQEAE KLKAQGEYSR
121 KLEERFMTLA ANHELMLRFK DEYKSENIKL REENEKLRLE NSSLFSQALK DEEAKVLQLT
181 VRCEALTGEL ETLKERCAQD ACQAQAREKE LLELQSQQAC THTKETEQLR SQLQTLKQQH
241 QQAVEQIAKA EETHSSLSQE LQARLQTVTR EKEELLQLSI ERGKVLQNKQ AEICQLEEKL
301 EIANEDRKHA LERFEQEAVA VDSNLRVREL QRKVDGIQKA YDELRLQSEA FKKHSLDLLS
361 KERELNGKLR HLSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCDC89 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- testis: 24 nTPM
- fallopian tube: 7.3 nTPM
- ovary: 4.1 nTPM
- endometrium: 2.4 nTPM
- retina: 1.5 nTPM
- seminal vesicle: 1.4 nTPM
Single-cell type
- early spermatids: 433 nCPM
- late primary spermatocytes: 364 nCPM
- fallopian tube ciliated cells: 49 nCPM
- respiratory ciliated cells: 39 nCPM
- late spermatids: 31 nCPM
- ependymal cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 3.3 nTPM
- midbrain: 3 nTPM
- cerebellum: 2.7 nTPM
- spinal cord: 2.6 nTPM
- white matter: 2.1 nTPM
- choroid plexus: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.06
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCDC89 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCDC89 as an antibody target. Whether an autoantibody or antibody against CCDC89 could matter depends on whether native CCDC89 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCDC89 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCDC89 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...